120 related articles for article (PubMed ID: 20801618)
1. Induced Sézary syndrome PBMCs poorly express immune response genes up-regulated in stimulated memory T cells.
Chong BF; Dantzer P; Germeroth T; Hafner M; Wilson AJ; Xiao G; Wong HK
J Dermatol Sci; 2010 Oct; 60(1):8-20. PubMed ID: 20801618
[TBL] [Abstract][Full Text] [Related]
2. Naïve/memory T-cell phenotypes in leukemic cutaneous T-cell lymphoma: Putative cell of origin overlaps disease classification.
Horna P; Moscinski LC; Sokol L; Shao H
Cytometry B Clin Cytom; 2019 May; 96(3):234-241. PubMed ID: 30328260
[TBL] [Abstract][Full Text] [Related]
3. CD164 identifies CD4
Benoit BM; Jariwala N; O'Connor G; Oetjen LK; Whelan TM; Werth A; Troxel AB; Sicard H; Zhu L; Miller C; Takeshita J; McVicar DW; Kim BS; Rook AH; Wysocka M
Arch Dermatol Res; 2017 Jan; 309(1):11-19. PubMed ID: 27766406
[TBL] [Abstract][Full Text] [Related]
4. Novel approach to gene expression profiling in Sézary syndrome.
Pomerantz RG; Mirvish ED; Erdos G; Falo LD; Geskin LJ
Br J Dermatol; 2010 Nov; 163(5):1090-4. PubMed ID: 20698843
[TBL] [Abstract][Full Text] [Related]
5. Augmentation in expression of activation-induced genes differentiates memory from naive CD4+ T cells and is a molecular mechanism for enhanced cellular response of memory CD4+ T cells.
Liu K; Li Y; Prabhu V; Young L; Becker KG; Munson PJ; Weng Np
J Immunol; 2001 Jun; 166(12):7335-44. PubMed ID: 11390484
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of circulating CD4+ memory T-cell subsets in erythrodermic patients: CD27 analysis can help to distinguish cutaneous T-cell lymphomas from inflammatory erythroderma.
Fierro MT; Novelli M; Quaglino P; Comessatti A; Fava P; Ortoncelli M; Ponti R; Bernengo MG
Dermatology; 2008; 216(3):213-21. PubMed ID: 18182812
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of lymphocyte interleukin-12 receptor expression in Sézary syndrome.
Zaki MH; Shane RB; Geng Y; Showe LC; Everetts SE; Presky DH; Wysocka M; Moore JS; Rook AH
J Invest Dermatol; 2001 Jul; 117(1):119-27. PubMed ID: 11442758
[TBL] [Abstract][Full Text] [Related]
8. Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7.
Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Lenz J; Speuser P; Erdmann S; Abuzahra F; Bowman E; Roszkiewicz J; Bieber T; Tüting T
Br J Dermatol; 2005 Feb; 152(2):258-64. PubMed ID: 15727636
[TBL] [Abstract][Full Text] [Related]
9. Th1 response and cytotoxicity genes are down-regulated in cutaneous T-cell lymphoma.
Hahtola S; Tuomela S; Elo L; Häkkinen T; Karenko L; Nedoszytko B; Heikkilä H; Saarialho-Kere U; Roszkiewicz J; Aittokallio T; Lahesmaa R; Ranki A
Clin Cancer Res; 2006 Aug; 12(16):4812-21. PubMed ID: 16914566
[TBL] [Abstract][Full Text] [Related]
10. From single-cell signature to prognostic factors: the case of Sézary syndrome.
Scala E; Narducci MG; Russo G
Expert Rev Clin Immunol; 2012 Nov; 8(8):699-701. PubMed ID: 23167680
[No Abstract] [Full Text] [Related]
11. Effector memory CD4(+) T cells differentially express activation associated molecules depending on the duration of American cutaneous leishmaniasis lesions.
de Oliveira Mendes-Aguiar C; Vieira-Gonçalves R; Guimarães LH; de Oliveira-Neto MP; Carvalho EM; Da-Cruz AM
Clin Exp Immunol; 2016 Aug; 185(2):202-9. PubMed ID: 27059407
[TBL] [Abstract][Full Text] [Related]
12. The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells.
Bernengo MG; Novelli M; Quaglino P; Lisa F; De Matteis A; Savoia P; Cappello N; Fierro MT
Br J Dermatol; 2001 Jan; 144(1):125-35. PubMed ID: 11167693
[TBL] [Abstract][Full Text] [Related]
13. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
[TBL] [Abstract][Full Text] [Related]
14. Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3.
Booken N; Gratchev A; Utikal J; Weiss C; Yu X; Qadoumi M; Schmuth M; Sepp N; Nashan D; Rass K; Tüting T; Assaf C; Dippel E; Stadler R; Klemke CD; Goerdt S
Leukemia; 2008 Feb; 22(2):393-9. PubMed ID: 18033314
[TBL] [Abstract][Full Text] [Related]
15. Absence of CD26 expression on skin-homing CLA+ CD4+ T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sézary syndrome.
Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Steitz J; Roszkiewicz J; Bieber T; Tüting T
Clin Exp Dermatol; 2005 Nov; 30(6):702-6. PubMed ID: 16197392
[TBL] [Abstract][Full Text] [Related]
16. Divergent LAG-3 versus BTLA, TIGIT, and FCRL3 expression in Sézary syndrome.
Anzengruber F; Ignatova D; Schlaepfer T; Chang YT; French LE; Pascolo S; Contassot E; Bobrowicz M; Hoetzenecker W; Guenova E
Leuk Lymphoma; 2019 Aug; 60(8):1899-1907. PubMed ID: 30638415
[TBL] [Abstract][Full Text] [Related]
17. TIGIT and Helios Are Highly Expressed on CD4
Jariwala N; Benoit B; Kossenkov AV; Oetjen LK; Whelan TM; Cornejo CM; Takeshita J; Kim BS; Showe LC; Wysocka M; Rook AH
J Invest Dermatol; 2017 Jan; 137(1):257-260. PubMed ID: 27592800
[No Abstract] [Full Text] [Related]
18. Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling.
Mehdi SJ; Moerman-Herzog AM; Wong HK
J Vis Exp; 2021 Oct; (176):. PubMed ID: 34723945
[TBL] [Abstract][Full Text] [Related]
19. Utility of flow cytometry immunophenotyping and DNA ploidy studies for diagnosis and characterization of blood involvement in CD4+ Sézary's syndrome.
Lima M; Almeida J; dos Anjos Teixeira M; Queiros ML; Santos AH; Fonseca S; Balanzategui A; Justica B; Orfao A
Haematologica; 2003 Aug; 88(8):874-87. PubMed ID: 12935975
[TBL] [Abstract][Full Text] [Related]
20. Unleashed monocytic engagement in Sézary syndrome during the combination of anti-CCR4 antibody with type I interferon.
Jiang TT; Kruglov O; Akilov OE
Blood Adv; 2024 May; 8(10):2384-2397. PubMed ID: 38489234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]